Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:
“Prognostic impact of molecular alterations in resected lung adeno and implications for TNM 10th edition.
EGFR, TP53, KRAS and ALK
TP53/KRAS: potential potential in stage I
ALK: downstaging potential in stages III–IV.”
Title: Brief Report: The Prognostic Impact of Common Molecular Alterations in Resected Lung Adenocarcinoma and Implications for the 10th Edition TNM Classification
Authors: Huatao Tang, Chaoqiang Deng, Hang Cao, Fangqiu Fu, Molin Zhang, Wangyang Zhu, Yuan Li, Yang Zhang, Haiquan Chen
Read the Full Article on JTO and JTO CRR.
Other articles featuring Hidehito Horinouchi on OncoDaily.